https://news.medxy.ai/zh/ct-deep-learning-lung/Medxy AIzh2026-10-20T03:18:01-07:00CT深度学习助力间质性肺异常预后评估 https://news.medxy.ai/ja/chest-ct-deep-learning/Medxy AIja2026-10-20T03:17:43-07:00胸部CT深層学習が間質性肺異常の予後予測を強化 https://news.medxy.ai/vi/deep-learning-ct/Medxy AIvi2026-10-20T03:17:22-07:00Deep learning trên phim CT giúp cải thiện dự báo tiên lượng bất thường kẽ phổi https://news.medxy.ai/deep-learning-on-ct-scans-enhances-prognostication-of-interstitial-lung-abnormalities/Medxy AIen2026-10-20T03:17:04-07:00Deep Learning on CT Scans Enhances Prognostication of Interstitial Lung Abnormalities https://news.medxy.ai/zh/eye-metastasis-study/Medxy AIzh2026-10-20T03:16:23-07:0040年眼部转移瘤研究：569例患者的临床特征、生存结局与治疗效果 https://news.medxy.ai/ja/eye-metastasis-study-2/Medxy AIja2026-10-20T03:16:05-07:0040年にわたる眼転移の臨床像：569例にみる生存と治療成績 https://news.medxy.ai/vi/eye-metastasis-study-3/Medxy AIvi2026-10-20T03:15:44-07:00Bức tranh lâm sàng về di căn vào mắt trong suốt 40 năm: Tỷ lệ sống sót và kết quả điều trị qua 569 trường hợp https://news.medxy.ai/ocular-metastasis-over-four-decades-clinical-patterns-survival-and-therapeutic-outcomes-in-569-patients/Medxy AIen2026-10-20T03:15:26-07:00Ocular Metastasis Over Four Decades: Clinical Patterns, Survival, and Therapeutic Outcomes in 569 Patients https://news.medxy.ai/zh/hpv-nasopharyngeal-carcinoma/Medxy AIzh2026-10-20T03:14:41-07:00HPV 阳性与角化性鼻咽癌：预后意义及临床启示 https://news.medxy.ai/ja/hpv-positive-nasopharyngeal-carcinoma/Medxy AIja2026-10-20T03:14:24-07:00角化型鼻咽頭癌におけるHPV陽性の意義：予後予測と臨床応用への示唆 https://news.medxy.ai/vi/hpv-positive-nasopharyngeal-carcinoma-2/Medxy AIvi2026-10-20T03:14:02-07:00HPV dương tính trong ung thư biểu mô vòm mũi họng sừng hóa: Ý nghĩa đối với tiên lượng và thực hành lâm sàng https://news.medxy.ai/hpv-positivity-in-keratinizing-nasopharyngeal-carcinoma-implications-for-prognosis-and-clinical-practice/Medxy AIen2026-10-20T03:13:44-07:00HPV Positivity in Keratinizing Nasopharyngeal Carcinoma: Implications for Prognosis and Clinical Practice https://news.medxy.ai/zh/social-determinants-colon-cancer/Medxy AIzh2026-10-20T03:12:58-07:00患者层面社会决定因素对结肠癌结局的影响：综合医疗网络中的新型预后指标 https://news.medxy.ai/ja/colorectal-cancer-outcomes/Medxy AIja2026-10-20T03:12:37-07:00大腸癌転帰に対する患者レベルの社会的決定要因の影響：統合医療ネットワークにおける新規予後指標 https://news.medxy.ai/vi/social-determinants-cancer/Medxy AIvi2026-10-20T03:12:17-07:00Yếu tố quyết định xã hội ở cấp độ bệnh nhân và kết cục ung thư đại tràng: một chỉ số tiên lượng mới trong mạng lưới y tế tích hợp https://news.medxy.ai/impact-of-patient-level-social-determinants-on-colon-cancer-outcomes-a-novel-prognostic-measure-within-an-integrated-health-network/Medxy AIen2026-10-20T03:11:59-07:00Impact of Patient-Level Social Determinants on Colon Cancer Outcomes: A Novel Prognostic Measure Within an Integrated Health Network https://news.medxy.ai/zh/metformin-progestin-therapy/Medxy AIzh2026-10-20T03:11:24-07:00二甲双胍联合孕激素用于子宫内膜肿瘤保留生育治疗：FELICIA 试验带来的启示 https://news.medxy.ai/ja/fertility-preservation-metformin/Medxy AIja2026-10-20T03:11:03-07:00子宮内膜腫瘍の妊孕性温存治療におけるメトホルミン併用の意義：FELICIA試験からの知見 https://news.medxy.ai/vi/metformin-progestin-fertility/Medxy AIvi2026-10-20T03:10:43-07:00Metformin hỗ trợ cùng progestin trong điều trị bảo tồn khả năng sinh sản cho tân sinh nội mạc tử cung: Góc nhìn từ thử nghiệm FELICIA https://news.medxy.ai/adjunctive-metformin-with-progestin-in-fertility-sparing-treatment-of-endometrial-neoplasia-insights-from-the-felicia-trial/Medxy AIen2026-10-20T03:10:25-07:00Adjunctive Metformin with Progestin in Fertility-Sparing Treatment of Endometrial Neoplasia: Insights from the FELICIA Trial https://news.medxy.ai/ja/legalized-sports-betting-health/Medxy AIja2026-10-20T02:39:44-07:00オンラインスポーツ賭博の合法化が精神保健医療利用に及ぼす影響 https://news.medxy.ai/vi/legal-sports-betting-behavioral-health/Medxy AIvi2026-10-20T02:39:18-07:00Hợp pháp hóa cá cược thể thao trực tuyến và việc sử dụng dịch vụ sức khỏe hành vi https://news.medxy.ai/online-sports-betting-legalization-and-behavioral-health-care-use/Medxy AIen2026-10-20T02:38:58-07:00Online Sports Betting Legalization and Behavioral Health Care Use https://news.medxy.ai/zh/ontario-icu-family-survey/Medxy AIzh2026-10-20T02:38:20-07:00安大略省 ICU 推行全省网络家属满意度调查：一项质量改进实践的启示 https://news.medxy.ai/ja/icu-family-satisfaction-survey/Medxy AIja2026-10-20T02:37:55-07:00オンタリオ州のICUで家族満足度を可視化：Web調査導入が示した質改善の示唆 https://news.medxy.ai/vi/implementing-a-provincial-web-based-family-satisfaction-survey-in-icus/Medxy AIvi2026-10-20T02:37:30-07:00Trực quan hóa mức độ hài lòng của gia đình tại các đơn vị chăm sóc đặc biệt (ICU) ở tỉnh Ontario: Những gợi ý về cải thiện chất lượng từ việc triển khai khảo sát trực tuyến https://news.medxy.ai/implementing-a-provincial-web-based-family-satisfaction-survey-in-icus-insights-from-ontarios-quality-improvement-initiative/Medxy AIen2026-10-20T02:37:05-07:00Implementing a Provincial Web-Based Family Satisfaction Survey in ICUs: Insights from Ontario’s Quality Improvement Initiative https://news.medxy.ai/zh/pulmonary-embolism-management-in-outpatient/Medxy AIzh2026-10-20T02:36:27-07:00如何推广急性低危肺栓塞的门诊管理：证据、实施与未来展望 https://news.medxy.ai/ja/outpatient-pulmonary-embolism-management/Medxy AIja2026-10-20T02:36:03-07:00急性低リスク肺塞栓症の外来管理をどう広げるか：エビデンス、実装、今後の展望 https://news.medxy.ai/vi/outpatient-pulmonary-embolism-care/Medxy AIvi2026-10-20T02:35:35-07:00Mở rộng điều trị ngoại trú cho thuyên tắc phổi cấp nguy cơ thấp: bằng chứng, triển khai và định hướng tương lai https://news.medxy.ai/adoption-of-outpatient-management-of-acute-low-risk-pulmonary-embolism-evidence-implementation-and-future-directions/Medxy AIen2026-10-20T02:35:04-07:00Adoption of Outpatient Management of Acute Low-Risk Pulmonary Embolism: Evidence, Implementation, and Future Directions https://news.medxy.ai/zh/low-breast-cancer-screening-rates/Medxy AIzh2026-10-20T02:34:09-07:00学术型基层医疗中住院医师乳腺癌筛查率偏低：差距如何缩小？ https://news.medxy.ai/ja/low-resident-breast-screening/Medxy AIja2026-10-20T02:33:45-07:00学術的プライマリケアにおける研修医の乳がん検診率の低さ：その格差をどう埋めるか https://news.medxy.ai/vi/narrowing-screening-gap/Medxy AIvi2026-10-20T02:33:17-07:00Thu hẹp khoảng cách: Giải quyết tỷ lệ tầm soát ung thư vú thấp ở bác sĩ nội trú trong chăm sóc ban đầu học thuật https://news.medxy.ai/ja/quantitative-ct-pulmonary-fibrosis/Medxy AIja2026-10-20T02:31:41-07:00進行性肺線維症における定量的CT：INBUILD試験サブスタディから得られた知見 https://news.medxy.ai/apoe-alleles-cognition-in-aging/Medxy AIen2026-10-20T02:31:39-07:00Impact of APOE ɛ4 and ɛ2 Alleles on Cognitive Trajectories in Nonagenarians and Beyond: Insights from the LifeAfter90 Study https://news.medxy.ai/vi/quantitative-ct-progressive-pulmonary-fibrosis/Medxy AIvi2026-10-20T02:31:19-07:00Chụp cắt lớp vi tính định lượng trong xơ phổi tiến triển: Những hiểu biết từ phân tích phụ của thử nghiệm INBUILD https://news.medxy.ai/zh/uveal-melanoma-gep-prame-prognosis/Medxy AIzh2026-10-20T02:30:22-07:00葡萄膜黑色素瘤的15-GEP/PRAME检测预后价值：有无确认性细胞病理学的比较 https://news.medxy.ai/ja/uveal-melanoma-gep-prame-test/Medxy AIja2026-10-20T02:29:55-07:00ぶどう膜黒色腫における15-GEP/PRAME検査の予後的価値：確認細胞病理の有無による差異を検討した Collaborative Ocular Oncology Group Study 2 からの知見 https://news.medxy.ai/vi/prognostic-value-in-uveal-melanoma/Medxy AIvi2026-10-20T02:29:27-07:00Giá trị tiên lượng của xét nghiệm 15-GEP/PRAME có hoặc không có tế bào học xác nhận trong u hắc tố màng bồ đào: Kết quả từ nghiên cứu Collaborative Ocular Oncology Group Study 2 https://news.medxy.ai/prognostic-value-of-15-gep-prame-assay-with-or-without-confirmatory-cytopathology-in-uveal-melanoma-insights-from-the-collaborative-ocular-oncology-group-study-2/Medxy AIen2026-10-20T02:29:04-07:00Prognostic Value of 15-GEP/PRAME Assay With or Without Confirmatory Cytopathology in Uveal Melanoma: Insights From the Collaborative Ocular Oncology Group Study 2 https://news.medxy.ai/zh/cannabis-opioid-use-2/Medxy AIzh2026-10-20T02:28:23-07:00大麻使用与头颈部游离皮瓣重建术后阿片类药物使用延长：临床证据综述 https://news.medxy.ai/ja/cannabis-opioid-use/Medxy AIja2026-10-20T02:28:01-07:00頭頸部遊離皮弁再建後の大麻使用とオピオイド長期使用：臨床エビデンスの統合 https://news.medxy.ai/vi/cannabis-opioid-use-after-surgery/Medxy AIvi2026-10-20T02:27:34-07:00Sử dụng cannabis và tình trạng dùng opioid kéo dài sau phẫu thuật tái tạo vạt tự do vùng đầu và cổ: Tổng hợp bằng chứng lâm sàng https://news.medxy.ai/cannabis-use-and-prolonged-opioid-utilization-after-head-and-neck-free-flap-reconstructive-surgery-a-clinical-evidence-synthesis/Medxy AIen2026-10-20T02:27:09-07:00Cannabis Use and Prolonged Opioid Utilization After Head and Neck Free Flap Reconstructive Surgery: A Clinical Evidence Synthesis https://news.medxy.ai/zh/academic-surgery-dei-policy/Medxy AIzh2026-10-20T02:26:25-07:00学术外科如何应对反DEI联邦政策：在多元、科研与公平之间寻求平衡 https://news.medxy.ai/ja/academic-surgery-for-dei-policy/Medxy AIja2026-10-20T02:26:02-07:00学術外科はいかにしてDEIに反対する連邦政策に対応すべきか――多様性、科学研究、公平性の間でのバランスの模索 https://news.medxy.ai/vi/anti-dei-federal-policies-in-academic-surgery/Medxy AIvi2026-10-20T02:25:35-07:00Cách thức ngành phẫu thuật trong môi trường học thuật ứng phó với các chính sách liên bang chống lại DEI (Đa dạng, Công bằng và Hòa nhập): Tìm kiếm sự cân bằng giữa đa dạng, nghiên cứu và công bằng https://news.medxy.ai/navigating-anti-dei-federal-policies-in-academic-surgery-strategies-to-sustain-diversity-research-and-equity/Medxy AIen2026-10-20T02:25:14-07:00Navigating Anti-DEI Federal Policies in Academic Surgery: Strategies to Sustain Diversity, Research, and Equity https://news.medxy.ai/zh/molecular-map-of-term-labor/Medxy AIzh2026-10-20T02:24:39-07:00解析足月分娩的分子图谱：宫颈扩张不同阶段的研究见解 https://news.medxy.ai/ja/decoding-labor-molecular-map/Medxy AIja2026-10-20T02:24:15-07:00正期産分娩の分子地図を読み解く：子宮頸管拡張段階からみた知見 https://news.medxy.ai/vi/human-labor-insights-across-cervical-dilatation/Medxy AIvi2026-10-20T02:23:41-07:00Giải mã bối cảnh phân tử của quá trình chuyển dạ đủ tháng: Những hiểu biết từ các nghiên cứu về những giai đoạn khác nhau của quá trình giãn cổ tử cung https://news.medxy.ai/decoding-the-molecular-landscape-of-human-labor-insights-across-cervical-dilatation-at-term/Medxy AIen2026-10-20T02:23:17-07:00Decoding the Molecular Landscape of Human Labor: Insights Across Cervical Dilatation at Term https://news.medxy.ai/zh/reassessing-easl-2025-benefits/Medxy AIzh2026-10-20T02:22:35-07:00重新审视 EASL 2025 标准：核苷（酸）类似物在慢性乙型肝炎中超出当前推荐范围的获益 https://news.medxy.ai/ja/reassessing-easl-2025-guidelines/Medxy AIja2026-10-20T02:22:11-07:00EASL 2025基準の再考：慢性B型肝炎におけるヌクレオシ(t)ドアナログの、現行推奨を超えた意義 https://news.medxy.ai/vi/reassessing-easl-2025-criteria/Medxy AIvi2026-10-20T02:21:42-07:00Đánh giá lại tiêu chí EASL 2025: Lợi ích của chất tương tự nucleos(t)ide trong viêm gan B mạn tính vượt ngoài khuyến cáo hiện hành https://news.medxy.ai/reevaluating-easl-2025-criteria-benefits-of-nucleostide-analogues-in-chronic-hepatitis-b-beyond-current-recommendations/Medxy AIen2026-10-20T02:21:19-07:00Reevaluating EASL 2025 Criteria: Benefits of Nucleos(t)ide Analogues in Chronic Hepatitis B Beyond Current Recommendations https://news.medxy.ai/zh/global-dementia-incidence-review-meta/Medxy AIzh2026-10-20T02:20:39-07:00全球各类原因所致痴呆症的发病：全面荟萃分析与最新研究发现 https://news.medxy.ai/ja/global-dementia-incidence-review/Medxy AIja2026-10-20T02:20:13-07:00世界の全原因認知症発症：包括的メタアナリシスと最新知見 https://news.medxy.ai/vi/global-incidence-of-all-cause-dementia-a-comprehensive-meta-analysis/Medxy AIvi2026-10-20T02:19:38-07:00Sự khởi phát chứng sa sút trí tuệ do mọi nguyên nhân trên toàn cầu: Phân tích gộp toàn diện và các phát hiện mới nhất https://news.medxy.ai/global-incidence-of-all-cause-dementia-a-comprehensive-meta-analysis-and-contemporary-insights/Medxy AIen2026-10-20T02:19:06-07:00Global Incidence of All-Cause Dementia: A Comprehensive Meta-Analysis and Contemporary Insights https://news.medxy.ai/zh/type-1-diabetes-mortality/Medxy AIzh2026-10-20T02:18:09-07:001型糖尿病的性别特异性死亡风险：近几十年先进治疗带来的启示 https://news.medxy.ai/ja/sex-differences-diabetes-mortality/Medxy AIja2026-10-20T02:17:47-07:001型糖尿病の死亡リスクにみられる性差：近年の先進医療が示す新たな知見 https://news.medxy.ai/vi/type-1-diabetes-mortality-risks/Medxy AIvi2026-10-20T02:17:20-07:00Đái tháo đường týp 1 và nguy cơ tử vong khác nhau theo giới: Góc nhìn từ nhiều thập kỷ điều trị hiện đại https://news.medxy.ai/sex-specific-mortality-risk-in-type-1-diabetes-insights-from-recent-decades-of-advanced-care/Medxy AIen2026-10-20T02:16:56-07:00Sex-Specific Mortality Risk in Type 1 Diabetes: Insights from Recent Decades of Advanced Care https://news.medxy.ai/zh/mitral-regurgitation-assessment-amyloid-cardiomyopathy/Medxy AIzh2026-10-20T02:16:19-07:00重新校准转甲状腺素蛋白淀粉样变性心肌病中的二尖瓣反流评估：一项多中心队列研究提升预后判别精度 https://news.medxy.ai/ja/mitral-regurgitation-amyloidosis/Medxy AIja2026-10-20T02:15:58-07:00トランスサイレチンアミロイド心筋症における僧帽弁逆流評価の再構築：多施設コホート研究が予後予測精度を高める https://news.medxy.ai/vi/refining-mitral-regurgitation-assessment-in-ttcr/Medxy AIvi2026-10-20T02:15:25-07:00Điều chỉnh lại phương pháp đánh giá hở van hai lá trong bệnh cơ tim do lắng đọng amyloid transthyretin https://news.medxy.ai/refining-mitral-regurgitation-assessment-in-transthyretin-amyloid-cardiomyopathy-a-multicenter-cohort-study-enhances-prognostic-precision/Medxy AIen2026-10-20T02:15:02-07:00Refining Mitral Regurgitation Assessment in Transthyretin Amyloid Cardiomyopathy: A Multicenter Cohort Study Enhances Prognostic Precision https://news.medxy.ai/zh/neoadjuvant-stereotactic-ablative-radiotherapy/Medxy AIzh2026-10-20T02:14:22-07:00肾细胞癌下腔静脉血栓切除术前的立体定向放射消融治疗：一项新的II期临床证据综述 https://news.medxy.ai/ja/stereotactic-radiotherapy-renal-cancer/Medxy AIja2026-10-20T02:14:01-07:00腎細胞癌の下大静脈血栓摘除術前に行う定位放射線焼灼療法：新たな第2相エビデンスの総括 https://news.medxy.ai/vi/neoadjuvant-stereotactic-ablative-radiotherapy-prior-to-inferior-vena-cava-thrombectomy/Medxy AIvi2026-10-20T02:13:32-07:00Xạ trị định vị (SBRT) trước phẫu thuật lấy huyết khối tĩnh mạch chủ dưới ở bệnh nhân ung thư biểu mô tế bào thận: Tổng quan các bằng chứng mới từ nghiên cứu giai đoạn 2 https://news.medxy.ai/neoadjuvant-stereotactic-ablative-radiotherapy-prior-to-inferior-vena-cava-thrombectomy-in-renal-cell-carcinoma-a-synthesis-of-emerging-phase-2-evidence/Medxy AIen2026-10-20T02:13:08-07:00Neoadjuvant Stereotactic Ablative Radiotherapy Prior to Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma: A Synthesis of Emerging Phase 2 Evidence https://news.medxy.ai/zh/swimming-health-education-low-back-pain/Medxy AIzh2026-10-20T02:12:19-07:00游泳联合健康教育：慢性下背痛管理的短期获益 https://news.medxy.ai/ja/swimming-plus-education-for-chronic-low-back-pain/Medxy AIja2026-10-20T02:11:56-07:00水泳と健康教育の併用：慢性腰痛管理における短期的な有益性 https://news.medxy.ai/vi/swimming-chronic-back-pain/Medxy AIvi2026-10-20T02:11:30-07:00Bơi lội kết hợp giáo dục: Lợi ích ngắn hạn trong kiểm soát đau thắt lưng mạn tính https://news.medxy.ai/swimming-plus-education-short-term-benefits-for-chronic-low-back-pain-management/Medxy AIen2026-10-20T02:11:09-07:00Swimming Plus Education: Short-Term Benefits for Chronic Low Back Pain Management https://news.medxy.ai/zh/patient-centered-rehabilitation-learning/Medxy AIzh2026-10-20T02:10:37-07:00借助以患者为中心的结局数据，推动康复照护升级与双向学习 https://news.medxy.ai/ja/patient-centered-rehabilitation-outcomes/Medxy AIja2026-10-20T02:10:15-07:00患者中心アウトカムデータを活かしたリハビリテーション医療の質向上と相互学習 https://news.medxy.ai/vi/patient-centered-rehabilitation-outcomes-2/Medxy AIvi2026-10-20T02:09:45-07:00Khai thác dữ liệu kết cục lấy người bệnh làm trung tâm để nâng cao chăm sóc phục hồi chức năng và học tập tương hỗ https://news.medxy.ai/harnessing-patient-centered-outcomes-data-for-enhanced-rehabilitation-care-and-reciprocal-learning/Medxy AIen2026-10-20T02:09:18-07:00Harnessing Patient-Centered Outcomes Data for Enhanced Rehabilitation Care and Reciprocal Learning https://news.medxy.ai/ja/intraoral-ultrasound-probing-depth/Medxy AIja2026-10-20T02:08:35-07:00口腔内超音波による頬側中央部プロービング深さ評価：概念実証の臨床的一致性研究 https://news.medxy.ai/vi/intraoral-ultrasound-periodontal-depth/Medxy AIvi2026-10-20T02:08:04-07:00Siêu âm trong miệng để đánh giá độ sâu thăm dò vùng giữa mặt ngoài: Nghiên cứu đồng thuận lâm sàng chứng minh khái niệm https://news.medxy.ai/intraoral-ultrasonography-for-mid-buccal-probing-depth-assessment-a-proof-of-concept-clinical-agreement-study/Medxy AIen2026-10-20T02:07:38-07:00Intraoral Ultrasonography for Mid-Buccal Probing Depth Assessment: A Proof-of-Concept Clinical Agreement Study https://news.medxy.ai/ja/icotrokinra-ulcerative-colitis-trial/Medxy AIja2026-10-20T02:06:59-07:00潰瘍性大腸炎に対するIcotrokinra第2相試験 https://news.medxy.ai/vi/oral-icotrokinra-colitis-trial/Medxy AIvi2026-10-20T02:06:31-07:00Icotrokinra đường uống trong viêm loét đại tràng: Kết quả đáng chú ý từ thử nghiệm pha 2 https://news.medxy.ai/phase-2-trial-of-icotrokinra-for-patients-with-ulcerative-colitis/Medxy AIen2026-10-20T02:06:13-07:00Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis https://news.medxy.ai/zh/peg-interferon-hepatic-immunity/Medxy AIzh2026-10-19T08:09:46-07:00核苷（酸）类似物停药后聚乙二醇干扰素α如何重塑慢性乙肝免疫反应 https://news.medxy.ai/ja/peg-interferon-immunity/Medxy AIja2026-10-19T08:09:26-07:00慢性B型肝炎におけるNUC中止後のペグ化インターフェロンαによる免疫調節の動態 https://news.medxy.ai/vi/pegylated-interferon-alpha/Medxy AIvi2026-10-19T08:08:29-07:00Pegylated Interferon-Alpha Sau Ngừng NUC: Điều Hòa Miễn Dịch Động Trong Viêm Gan B Mạn Tính https://news.medxy.ai/dynamic-immune-modulation-by-pegylated-interferon-alpha-post-nuc-withdrawal-in-chronic-hepatitis-b/Medxy AIen2026-10-19T08:08:11-07:00Dynamic Immune Modulation by Pegylated Interferon-Alpha Post-NUC Withdrawal in Chronic Hepatitis B https://news.medxy.ai/zh/epilepsy-risk-dementia/Medxy AIzh2026-10-19T08:07:25-07:00癫痫：年轻发病型痴呆的重要危险因素——来自法国和瑞典全国性研究的证据 https://news.medxy.ai/ja/epilepsy-dementia-risk/Medxy AIja2026-10-19T08:07:06-07:00てんかんは若年発症認知症の重要な危険因子か――フランス・スウェーデン全国研究から見えた実態 https://news.medxy.ai/vi/epilepsy-early-dementia-risk/Medxy AIvi2026-10-19T08:06:42-07:00Động kinh: yếu tố nguy cơ đáng kể của sa sút trí tuệ khởi phát sớm qua dữ liệu toàn quốc từ Pháp và Thụy Điển https://news.medxy.ai/epilepsy-as-a-significant-risk-factor-for-young-onset-dementia-insights-from-nationwide-studies-in-france-and-sweden/Medxy AIen2026-10-19T08:06:25-07:00Epilepsy as a Significant Risk Factor for Young-Onset Dementia: Insights from Nationwide Studies in France and Sweden https://news.medxy.ai/zh/oral-glp1-agonist-2/Medxy AIzh2026-10-19T08:05:44-07:00HRS-7535：为二甲双胍与SGLT2抑制剂控制不佳的2型糖尿病带来新希望的口服GLP-1受体激动剂 https://news.medxy.ai/ja/oral-glp1-agents/Medxy AIja2026-10-19T08:05:25-07:00HRS-7535：メトホルミンとSGLT2阻害薬で不十分な2型糖尿病に期待される経口GLP-1受容体作動薬 https://news.medxy.ai/vi/hrs-7535-metformin-and-sglt2-inhibitors/Medxy AIvi2026-10-19T08:05:03-07:00HRS-7535: Thuốc chủ vận thụ thể GLP-1 dạng uống đầy hứa hẹn cho bệnh tiểu đường loại 2 khi điều trị bằng metformin và thuốc ức chế SGLT2 không đạt hiệu quả như mong đợi https://news.medxy.ai/hrs-7535-a-promising-oral-glp-1-receptor-agonist-for-type-2-diabetes-uncontrolled-by-metformin-and-sglt2-inhibitors/Medxy AIen2026-10-19T08:04:44-07:00HRS-7535: A Promising Oral GLP-1 Receptor Agonist for Type 2 Diabetes Uncontrolled by Metformin and SGLT2 Inhibitors https://news.medxy.ai/ja/mechanical-circulatory-support/Medxy AIja2026-10-19T08:03:56-07:00心原性ショックにおける一時的機械的循環補助：2026年EAPCI–ACVCコンセンサスの重要推奨 https://news.medxy.ai/vi/temporary-mechanical-circulation-support/Medxy AIvi2026-10-19T08:03:22-07:00Hỗ trợ tuần hoàn cơ học tạm thời trong sốc tim: Các khuyến nghị then chốt từ đồng thuận EAPCI–ACVC năm 2026 https://news.medxy.ai/zh/mechanical-support-consensus/Medxy AIzh2026-10-19T08:02:51-07:00心源性休克中的临时机械循环支持：2026 年 EAPCI–ACVC 共识关键建议 https://news.medxy.ai/mechanical-support-cardiogenic-shock/Medxy AIen2026-10-19T08:02:22-07:00Temporary Mechanical Circulatory Support in Cardiogenic Shock: Key Recommendations from the 2026 EAPCI–ACVC Consensus https://news.medxy.ai/zh/post-covid-health/Medxy AIzh2026-10-19T08:01:12-07:00COVID-19 康复后的身体活动与器官健康：来自幸存者队列研究的启示 https://news.medxy.ai/ja/covid19-physical-activity/Medxy AIja2026-10-19T08:00:55-07:00COVID-19後の身体活動と臓器機能：生存者コホート研究からみえた知見 https://news.medxy.ai/vi/physical-activity-health-covid19/Medxy AIvi2026-10-19T08:00:38-07:00Hoạt động thể chất và sức khỏe cơ quan sau COVID-19: Góc nhìn từ một nghiên cứu đoàn hệ ở người sống sót https://news.medxy.ai/physical-activity-and-organ-health-after-covid-19-insights-from-a-survivor-cohort-study/Medxy AIen2026-10-19T08:00:21-07:00Physical Activity and Organ Health After COVID-19: Insights from a Survivor Cohort Study https://news.medxy.ai/zh/hospital-daycare/Medxy AIzh2026-10-19T07:59:40-07:00病房里的白天：急性与康复住院患者如何度过每一天 https://news.medxy.ai/ja/patient-life/Medxy AIja2026-10-19T07:59:24-07:00病棟の中で患者はどう過ごしているのか――急性期・リハビリ病棟における入院生活の実態 https://news.medxy.ai/vi/hospital-patient-routine/Medxy AIvi2026-10-19T07:59:04-07:00Sau cánh cửa bệnh viện: Bệnh nhân nội trú dành thời gian trong ngày như thế nào ở khoa cấp tính và phục hồi chức năng https://news.medxy.ai/behind-hospital-doors-how-inpatients-spend-their-days-in-acute-and-rehabilitation-settings/Medxy AIen2026-10-19T07:58:40-07:00Behind Hospital Doors: How Inpatients Spend Their Days in Acute and Rehabilitation Settings https://news.medxy.ai/zh/acid-types-fluoride-gel-effects/Medxy AIzh2026-10-19T07:57:51-07:00酸的类型如何影响实验性氟化物凝胶对牙釉质抗侵蚀的效果 https://news.medxy.ai/ja/acid-types-enamel-protection/Medxy AIja2026-10-19T07:57:34-07:00酸の種類が左右する？ 実験的フッ化物ゲルによるエナメル質保護効果の検討 https://news.medxy.ai/vi/acid-effect-fluoride-gels/Medxy AIvi2026-10-19T07:57:12-07:00Ảnh hưởng của loại acid đến hiệu quả của các gel fluoride thực nghiệm trong bảo vệ men răng khỏi xói mòn https://news.medxy.ai/impact-of-acid-type-on-the-efficacy-of-experimental-fluoride-gels-in-protecting-enamel-from-erosion/Medxy AIen2026-10-19T07:56:54-07:00Impact of Acid Type on the Efficacy of Experimental Fluoride Gels in Protecting Enamel from Erosion https://news.medxy.ai/zh/isoflurane-based-inhaled-sedation-for-acute-hypoxemic-respiratory-failure/Medxy AIzh2026-10-19T07:56:14-07:00针对急性低氧性呼吸衰竭的异氟烷吸入镇静：来自SAVE-ICU随机临床试验的发现 https://news.medxy.ai/ja/isoflurane-sedation-acute-hypoxia/Medxy AIja2026-10-19T07:55:53-07:00急性低酸素性呼吸不全に対するイソフルラン吸入鎮静：SAVE-ICUランダム化臨床試験から得られた知見 https://news.medxy.ai/vi/isoflurane-respiratory-failure/Medxy AIvi2026-10-19T07:55:30-07:00An thần hít bằng isoflurane trong suy hô hấp giảm oxy máu cấp tính: Góc nhìn từ thử nghiệm lâm sàng ngẫu nhiên SAVE-ICU https://news.medxy.ai/isoflurane-based-inhaled-sedation-for-acute-hypoxemic-respiratory-failure-insights-from-the-save-icu-randomized-clinical-trial/Medxy AIen2026-10-19T07:55:08-07:00Isoflurane-Based Inhaled Sedation for Acute Hypoxemic Respiratory Failure: Insights from the SAVE-ICU Randomized Clinical Trial https://news.medxy.ai/zh/pediatric-sepsis-alerts-pesm/Medxy AIzh2026-10-19T07:54:15-07:00急诊科商用儿童脓毒症早期预警系统的评估：有效性、公平性及临床意义 https://news.medxy.ai/ja/pediatric-sepsis-alerts/Medxy AIja2026-10-19T07:53:54-07:00救急外来における商用小児敗血症早期警報の評価：有効性・公平性・臨床的意義 https://news.medxy.ai/vi/pediatric-sepsis-early-detection-alert-in-emergency/Medxy AIvi2026-10-19T07:53:31-07:00Đánh giá hệ thống cảnh báo sớm nhiễm khuẩn huyết ở trẻ em mang tính thương mại tại khoa cấp cứu: Hiệu quả, tính công bằng và ý nghĩa lâm sàng https://news.medxy.ai/evaluation-of-a-commercial-pediatric-sepsis-early-detection-alert-in-emergency-departments-efficacy-equity-and-clinical-implications/Medxy AIen2026-10-19T07:53:10-07:00Evaluation of a Commercial Pediatric Sepsis Early Detection Alert in Emergency Departments: Efficacy, Equity, and Clinical Implications https://news.medxy.ai/zh/sle-score-prediction/Medxy AIzh2026-10-19T07:52:10-07:00系统性红斑狼疮新型加权复发评分可提升器官损伤预测能力 https://news.medxy.ai/ja/sle-organ-damage-prediction/Medxy AIja2026-10-19T07:51:37-07:00新しい重み付けフレアスコアがSLEの臓器障害予測をさらに高める https://news.medxy.ai/vi/weighted-flare-score/Medxy AIvi2026-10-19T07:51:01-07:00Thang điểm bùng phát có trọng số mới giúp dự đoán tổn thương cơ quan trong lupus ban đỏ hệ thống https://news.medxy.ai/a-novel-weighted-flare-score-enhances-prediction-of-organ-damage-in-systemic-lupus-erythematosus/Medxy AIen2026-10-19T07:50:43-07:00A Novel Weighted Flare Score Enhances Prediction of Organ Damage in Systemic Lupus Erythematosus https://news.medxy.ai/zh/prioritize-lung-transplant-outcomes/Medxy AIzh2026-10-19T07:49:58-07:00优先排序对肺移植后重度原发性移植物功能障碍的影响：风险因素与结局的解析 https://news.medxy.ai/ja/lung-transplant-failure/Medxy AIja2026-10-19T07:49:41-07:00肺移植後の重症原発性移植片機能不全に対する優先順位付けの影響：危険因子と転帰の分離 https://news.medxy.ai/vi/primary-graft-dysfunction/Medxy AIvi2026-10-19T07:49:18-07:00Tác động của việc ưu tiên đến rối loạn chức năng mảnh ghép nguyên phát nặng sau ghép phổi: Tách bạch các yếu tố nguy cơ và kết cục https://news.medxy.ai/impact-of-prioritization-on-severe-primary-graft-dysfunction-after-lung-transplantation-disentangling-risk-factors-and-outcomes/Medxy AIen2026-10-19T07:47:10-07:00Impact of Prioritization on Severe Primary Graft Dysfunction After Lung Transplantation: Disentangling Risk Factors and Outcomes https://news.medxy.ai/zh/lichen-cancer-risk/Medxy AIzh2026-10-19T07:46:29-07:00扁平苔藓会增加癌症风险吗？——丹麦全国队列研究带来的启示 https://news.medxy.ai/ja/lichen-planus-cancer-risk/Medxy AIja2026-10-19T07:46:11-07:00扁平苔癬におけるがんリスク：デンマーク全国コホート研究が示す臨床的示唆 https://news.medxy.ai/vi/lichen-planus-cancer-risk-2/Medxy AIvi2026-10-19T07:45:49-07:00Lichen planus làm tăng nguy cơ ung thư: Gợi ý từ một nghiên cứu đoàn hệ quy mô toàn quốc tại Đan Mạch https://news.medxy.ai/cancer-risks-in-lichen-planus-implications-from-a-nationwide-danish-cohort-study/Medxy AIen2026-10-19T07:45:26-07:00Cancer Risks in Lichen Planus: Implications from a Nationwide Danish Cohort Study https://news.medxy.ai/zh/belotero-intense-lip-augmentation/Medxy AIzh2026-10-19T07:44:46-07:00Belotero Intense 联合利多卡因用于唇部增大：多中心随机研究证实其安全性与有效性 https://news.medxy.ai/ja/belotero-intense-efficacy/Medxy AIja2026-10-19T07:44:28-07:00唇増大におけるBelotero Intense with lidocaineの有用性を検証：多施設無作為化試験で安全性と有効性を確認 https://news.medxy.ai/vi/belotero-intense-lip-volume/Medxy AIvi2026-10-19T07:43:56-07:00Belotero Intense có lidocaine cho tăng thể tích môi: Nghiên cứu ngẫu nhiên đa trung tâm cho thấy tính an toàn và hiệu quả https://news.medxy.ai/evaluating-belotero-intense-with-lidocaine-for-lip-augmentation-a-multicenter-randomized-study-demonstrates-safety-and-efficacy/Medxy AIen2026-10-19T07:43:38-07:00Evaluating Belotero Intense with Lidocaine for Lip Augmentation: A Multicenter Randomized Study Demonstrates Safety and Efficacy https://news.medxy.ai/zh/glp-1-receptor-agonists-and-psychiatric-acute-care-outcomes-in-schizophrenia-with-type-2-diabetes/Medxy AIzh2026-10-19T07:43:03-07:00精神分裂症合并2型糖尿病患者使用GLP-1受体激动剂与急性精神科治疗结局：来自真实世界临床实践中电子健康记录（EHR）数据的启示 https://news.medxy.ai/ja/glp-1-receptor-agonists-and-psychiatric-acute-care-outcomes-in-schizophrenia-with-t2dm/Medxy AIja2026-10-19T07:42:29-07:00統合失調症および2型糖尿病を合併する患者におけるGLP-1受容体作動薬と精神科急性期ケアの転帰 https://news.medxy.ai/vi/glp-1-agonists-psychiatric-care/Medxy AIvi2026-10-19T07:42:06-07:00Chất chủ vận thụ thể GLP-1 và kết cục chăm sóc cấp tính tâm thần ở bệnh nhân tâm thần phân liệt kèm đái tháo đường týp 2: Góc nhìn từ dữ liệu EHR trong thực hành lâm sàng thực tế https://news.medxy.ai/glp-1-receptor-agonists-and-psychiatric-acute-care-outcomes-in-schizophrenia-with-type-2-diabetes-insights-from-real-world-ehr-data/Medxy AIen2026-10-19T07:41:46-07:00GLP-1 Receptor Agonists and Psychiatric Acute-Care Outcomes in Schizophrenia with Type 2 Diabetes: Insights from Real-World EHR Data https://news.medxy.ai/zh/oliguria-threshold-review/Medxy AIzh2026-10-19T07:40:53-07:00重症监护中少尿阈值需重新审视：对AKI、CKD及死亡风险的启示 https://news.medxy.ai/vi/oliguria-threshold-review-2/Medxy AIvi2026-10-19T07:40:14-07:00Xem lại ngưỡng thiểu niệu trong hồi sức tích cực: ý nghĩa đối với AKI, CKD và nguy cơ tử vong https://news.medxy.ai/reevaluating-oliguria-thresholds-in-critical-care-implications-for-aki-ckd-and-mortality-risk/Medxy AIen2026-10-19T07:39:57-07:00Reevaluating Oliguria Thresholds in Critical Care: Implications for AKI, CKD, and Mortality Risk https://news.medxy.ai/zh/mitochondrial-transfer-aml/Medxy AIzh2026-10-19T07:39:15-07:00隧道纳米管介导的线粒体转运：儿童AML中巨噬细胞免疫抑制的新机制 https://news.medxy.ai/ja/mitochondrial-transfer-in-pediatric-aml/Medxy AIja2026-10-19T07:38:55-07:00トンネルナノチューブを介したミトコンドリア輸送：小児AMLにおけるマクロファージの免疫抑制に関する新たなメカニズム https://news.medxy.ai/vi/mitochondria-transfer-aml/Medxy AIvi2026-10-19T07:38:31-07:00Chuyển giao Mitochondria qua Tunneling Nanotubes: Cơ chế Mới về Ức chế Miễn dịch do Đại thực bào Trung gian trong AML Trẻ em https://news.medxy.ai/mitochondrial-transfer-via-tunneling-nanotubes-a-novel-mechanism-of-macrophage-mediated-immunosuppression-in-pediatric-aml/Medxy AIen2026-10-19T07:38:09-07:00Mitochondrial Transfer via Tunneling Nanotubes: A Novel Mechanism of Macrophage-Mediated Immunosuppression in Pediatric AML https://news.medxy.ai/zh/85727-2/Medxy AIzh2026-10-19T07:37:27-07:00急性呼吸衰竭中针对支气管分泌物过多的高频胸壁振荡疗法：证据梳理与临床意义 https://news.medxy.ai/ja/high-frequency-chest-wall-vibration/Medxy AIja2026-10-19T07:37:05-07:00急性呼吸不全における気管支分泌物過剰への高頻度胸壁振動療法：エビデンスの整理と臨床的意義 https://news.medxy.ai/vi/high-frequency-chest-oscillation/Medxy AIvi2026-10-19T07:36:39-07:00Dao động thành ngực tần số cao trong suy hô hấp cấp kèm tăng tiết phế quản: Tổng hợp bằng chứng và ý nghĩa lâm sàng https://news.medxy.ai/high-frequency-chest-wall-oscillation-in-acute-respiratory-failure-with-bronchial-hypersecretion-evidence-synthesis-and-clinical-implications/Medxy AIen2026-10-19T07:36:13-07:00High-Frequency Chest Wall Oscillation in Acute Respiratory Failure With Bronchial Hypersecretion: Evidence Synthesis and Clinical Implications https://news.medxy.ai/zh/spending-on-corrective-lenses/Medxy AIzh2026-10-19T07:34:34-07:00矫正镜片支出的趋势：关于费用、障碍及政策启示的证据综述 https://news.medxy.ai/ja/corrective-lenses-costs/Medxy AIja2026-10-19T07:34:14-07:00矯正レンズ支出の動向：費用・障壁・政策含意をめぐるエビデンスレビュー https://news.medxy.ai/vi/trends-in-spending-on-corrective-lenses/Medxy AIvi2026-10-19T07:33:49-07:00Xu hướng chi tiêu cho thấu kính điều chỉnh thị lực: Tổng quan bằng chứng về chi phí, rào cản và các hàm ý chính sách https://news.medxy.ai/trends-in-spending-on-corrective-lenses-an-evidence-based-review-on-expenditures-barriers-and-policy-implications/Medxy AIen2026-10-19T07:33:24-07:00Trends in Spending on Corrective Lenses: An Evidence-Based Review on Expenditures, Barriers, and Policy Implications https://news.medxy.ai/zh/hearing-loss-genetics/Medxy AIzh2026-10-19T07:32:24-07:00基于精准听力表型提升感音神经性听力损失的遗传发现 https://news.medxy.ai/ja/genetic-discovery-hearing-loss/Medxy AIja2026-10-19T07:32:03-07:00純音聴力検査による精密表現型解析で切り拓く感音難聴の遺伝学的発見 https://news.medxy.ai/vi/genetic-hearing-loss/Medxy AIvi2026-10-19T07:31:40-07:00Tăng cường phát hiện di truyền trong suy giảm thính lực tiếp nhận do tổn thương thần kinh bằng định kiểu hình thính lực chính xác https://news.medxy.ai/enhancing-genetic-discovery-in-sensorineural-hearing-loss-through-precision-audiometric-phenotyping/Medxy AIen2026-10-19T07:31:19-07:00Enhancing Genetic Discovery in Sensorineural Hearing Loss Through Precision Audiometric Phenotyping https://news.medxy.ai/zh/weight-loss-surgery-cancer-risk/Medxy AIzh2026-10-19T07:30:36-07:00减重手术与肥胖相关癌症风险：年龄与性别视角下的综合综述 https://news.medxy.ai/ja/weight-loss-surgery-cancer-risk-2/Medxy AIja2026-10-19T07:29:59-07:00年齢と性別でみた減量手術と肥満関連がんリスク：包括的レビュー https://news.medxy.ai/vi/85686-2/Medxy AIvi2026-10-19T07:29:36-07:00Phẫu thuật giảm cân và nguy cơ mắc các bệnh ung thư liên quan đến béo phì: Tổng quan toàn diện dưới góc độ tuổi tác và giới tính https://news.medxy.ai/bariatric-surgery-and-risk-of-obesity-related-cancer-by-age-and-sex-a-comprehensive-review/Medxy AIen2026-10-19T07:29:13-07:00Bariatric Surgery and Risk of Obesity-Related Cancer by Age and Sex: A Comprehensive Review https://news.medxy.ai/zh/perineal-tear-incontinence/Medxy AIzh2026-10-19T07:28:16-07:00初产妇严重会阴撕裂后1年肛门失禁的预测：一项实用风险模型的构建与验证 https://news.medxy.ai/ja/predicting-anal-incontinence-one-year-after-severe-perineal-tears-in-primiparous-women/Medxy AIja2026-10-19T07:28:00-07:00初産婦における重度会陰裂傷1年後の肛門失禁の予測：実用的なリスクモデルの構築と検証 https://news.medxy.ai/vi/postpartum-stool-leakage-prediction/Medxy AIvi2026-10-19T07:27:41-07:00Dự đoán són phân sau 1 năm ở phụ nữ sinh con lần đầu bị rách tầng sinh môn nặng: xây dựng và thẩm định một mô hình nguy cơ thực hành https://news.medxy.ai/predicting-anal-incontinence-one-year-after-severe-perineal-tears-in-primiparous-women-development-and-validation-of-a-practical-risk-model/Medxy AIen2026-10-19T07:27:24-07:00Predicting Anal Incontinence One Year After Severe Perineal Tears in Primiparous Women: Development and Validation of a Practical Risk Model https://news.medxy.ai/zh/calprotectin-crohns-risk/Medxy AIzh2026-10-19T07:26:41-07:00用粪便钙卫蛋白识别高风险人群中的克罗恩病临床前阶段：预防试验的新框架 https://news.medxy.ai/ja/crohns-preclinical-detection/Medxy AIja2026-10-19T07:26:24-07:00糞便カルプロテクチンで高リスク者のCrohn病前臨床期を見いだす――予防試験に向けた新たな枠組み https://news.medxy.ai/vi/crohns-preclinical-detection-2/Medxy AIvi2026-10-19T07:25:48-07:00Nhận diện bệnh Crohn tiền lâm sàng ở người nguy cơ cao bằng calprotectin trong phân: một khung mới cho các thử nghiệm phòng ngừa https://news.medxy.ai/identifying-preclinical-crohns-disease-in-high-risk-individuals-using-faecal-calprotectin-a-new-framework-for-prevention-trials/Medxy AIen2026-10-19T07:25:27-07:00Identifying Preclinical Crohn’s Disease in High-Risk Individuals Using Faecal Calprotectin: A New Framework for Prevention Trials https://news.medxy.ai/assessing-early-pregnancy-exposure-to-anti-cgrp-monoclonal-antibodies-and-propranolol-implications-for-spontaneous-abortion-risk/Medxy AIen2026-10-19T07:23:40-07:00Assessing Early Pregnancy Exposure to Anti-CGRP Monoclonal Antibodies and Propranolol: Implications for Spontaneous Abortion Risk https://news.medxy.ai/ja/waist-circumference-surpasses-cardiometabolic/Medxy AIja2026-10-19T07:23:01-07:00クラインフェルター症候群における性腺機能低下症の検出において、ウエスト周囲径は心血管・代謝指標よりも優れている https://news.medxy.ai/vi/waist-circumference-klinefelter/Medxy AIvi2026-10-19T07:22:40-07:00Chu vi vòng eo vượt trội hơn các chỉ số tim mạch-chuyển hóa trong phát hiện suy sinh dục ở Hội chứng Klinefelter https://news.medxy.ai/waist-circumference-surpasses-cardiometabolic-indices-in-identifying-hypogonadism-in-klinefelter-syndrome/Medxy AIen2026-10-19T07:22:22-07:00Waist Circumference Surpasses Cardiometabolic Indices in Identifying Hypogonadism in Klinefelter Syndrome https://news.medxy.ai/zh/early-heart-failure-discharge/Medxy AIzh2026-10-19T07:21:38-07:00心力衰竭早期出院新方案：皮下呋塞米助力康复并缩短住院时间 https://news.medxy.ai/ja/subcutaneous-furosemide/Medxy AIja2026-10-19T07:21:19-07:00心不全の早期退院を支える皮下フロセミド：回復促進と入院短縮に向けた新戦略 https://news.medxy.ai/vi/early-discharge-furosemide/Medxy AIvi2026-10-19T07:20:57-07:00Xuất viện sớm sáng tạo với furosemide tiêm dưới da trong suy tim: cải thiện phục hồi, rút ngắn thời gian nằm viện https://news.medxy.ai/innovative-early-discharge-with-subcutaneous-furosemide-for-heart-failure-enhancing-recovery-and-reducing-hospital-stay/Medxy AIen2026-10-19T07:20:36-07:00Innovative Early Discharge with Subcutaneous Furosemide for Heart Failure: Enhancing Recovery and Reducing Hospital Stay https://news.medxy.ai/zh/pie-crusting-safety/Medxy AIzh2026-10-19T07:19:54-07:00高等级经皮内侧副韧带 Pie-crusting 的安全性评估：对膝关节外翻稳定性的意义 https://news.medxy.ai/ja/high-grade-percutaneous-mcl-pie-crusting-in-medial-meniscus-surgery/Medxy AIja2026-10-19T07:19:35-07:00高グレード内側側副靭帯に対する「パイクラースティング（Pie-crusting）」の安全性評価：膝関節外反安定性への意義 https://news.medxy.ai/vi/high-grade-percutaneous-in-medial-meniscus-surgery/Medxy AIvi2026-10-19T07:19:15-07:00Đánh giá độ an toàn của kỹ thuật “pie-crusting” (tạo các vết cắt nhỏ) trên dây chằng bên trong https://news.medxy.ai/evaluating-the-safety-of-high-grade-percutaneous-mcl-pie-crusting-in-medial-meniscus-surgery-implications-for-valgus-stability/Medxy AIen2026-10-19T07:18:51-07:00Evaluating the Safety of High-Grade Percutaneous MCL Pie-Crusting in Medial Meniscus Surgery: Implications for Valgus Stability https://news.medxy.ai/zh/early-pregnancy-cgrp-beta-blockers/Medxy AIzh2026-10-18T07:24:44-07:00妊娠早期暴露于抗CGRP单克隆抗体与普萘洛尔：对自然流产风险的影响 https://news.medxy.ai/ja/early-pregnancy-cgrp-exposure/Medxy AIja2026-10-18T07:24:24-07:00妊娠初期の抗CGRP抗体・プロプラノロール曝露を検証　自然流産リスクへの影響 https://news.medxy.ai/vi/anti-cgrp-propranolol-risk/Medxy AIvi2026-10-18T07:24:01-07:00Phơi Nhiễm Anti-CGRP mAbs và Propranolol Trong Đầu Thai Kỳ: Nguy Cơ Sẩy Thai Tự Nhiên Có Tăng? https://news.medxy.ai/zh/85654-2/Medxy AIzh2026-10-18T07:18:11-07:00脊髓刺激疗法联合由物理治疗师主导的运动及运动处方对慢性神经病理性疼痛的长期疗效 https://news.medxy.ai/ja/spinal-stimulation-therapy/Medxy AIja2026-10-18T07:17:49-07:00慢性神経障害性疼痛に対する脊髄刺激療法と理学療法士主導運動・運動処方併用の長期効果：臨床レビュー https://news.medxy.ai/vi/85652-2/Medxy AIvi2026-10-18T07:17:27-07:00Hiệu quả lâu dài của liệu pháp kích thích tủy sống kết hợp với các bài tập và chương trình vận động do chuyên gia vật lý trị liệu hướng dẫn trong điều trị đau thần kinh mãn tính https://news.medxy.ai/long-term-effects-of-spinal-cord-stimulation-combined-with-physiotherapist-led-exercise-and-prescribed-physical-activity-in-chronic-neuropathic-pain-a-clinical-review/Medxy AIen2026-10-18T07:17:01-07:00Long-term Effects of Spinal Cord Stimulation Combined with Physiotherapist-led Exercise and Prescribed Physical Activity in Chronic Neuropathic Pain: A Clinical Review https://news.medxy.ai/zh/local-factors-implant-complications/Medxy AIzh2026-10-18T07:16:09-07:00影响种植体并发症的局部因素：来自挪威人群研究的启示 https://news.medxy.ai/ja/85648-2-85648/Medxy AIja2026-10-18T07:15:49-07:00インプラントの合併症に影響を及ぼす局所的因子：ノルウェーの集団研究からの示唆 https://news.medxy.ai/vi/85647-2-85647/Medxy AIvi2026-10-18T07:15:27-07:00Các yếu tố tại chỗ ảnh hưởng đến biến chứng cấy ghép: Thông tin từ một nghiên cứu dựa trên quần thể tại Na Uy https://news.medxy.ai/local-factors-influencing-implant-related-complications-insights-from-a-norwegian-population-study/Medxy AIen2026-10-18T07:15:08-07:00Local Factors Influencing Implant-Related Complications: Insights from a Norwegian Population Study https://news.medxy.ai/zh/ai-assessment-primary-care/Medxy AIzh2026-10-18T07:14:20-07:00急诊初级保健中的对话式AI评估：Articulate Medical Intelligence Explorer的前瞻性可行性研究 https://news.medxy.ai/ja/ai-primary-care-evaluation/Medxy AIja2026-10-18T07:14:01-07:00救急一次診療における対話型AIの評価：Articulate Medical Intelligence Explorerの前向き実現可能性研究 https://news.medxy.ai/vi/ai-chatbot-evaluation/Medxy AIvi2026-10-18T07:13:41-07:00Đánh giá AI hội thoại trong chăm sóc ban đầu khẩn cấp: Nghiên cứu khả thi tiến cứu về Articulate Medical Intelligence Explorer https://news.medxy.ai/evaluating-conversational-ai-in-urgent-primary-care-a-prospective-feasibility-study-of-the-articulate-medical-intelligence-explorer/Medxy AIen2026-10-18T07:13:22-07:00Evaluating Conversational AI in Urgent Primary Care: A Prospective Feasibility Study of the Articulate Medical Intelligence Explorer https://news.medxy.ai/zh/home-care-safety-children/Medxy AIzh2026-10-18T07:12:38-07:00医疗复杂儿童居家照护安全如何守护：父母面临的挑战与创新应对 https://news.medxy.ai/ja/home-care-safety-kids/Medxy AIja2026-10-18T07:12:20-07:00医療的複雑性を有する子どもの在宅ケア安全をどう守るか：保護者が直面する課題と工夫 https://news.medxy.ai/vi/home-care-challenges/Medxy AIvi2026-10-18T07:12:00-07:00An toàn chăm sóc tại nhà cho trẻ có bệnh cảnh y khoa phức tạp: thách thức của phụ huynh và những sáng kiến thực tiễn https://news.medxy.ai/navigating-home-care-safety-for-children-with-medical-complexity-parental-challenges-and-innovations/Medxy AIen2026-10-18T07:11:41-07:00Navigating Home Care Safety for Children with Medical Complexity: Parental Challenges and Innovations https://news.medxy.ai/zh/axial-spa-diagnosis/Medxy AIzh2026-10-18T07:11:02-07:00集中式专家复核可提升轴性脊柱关节炎诊断准确性：来自多中心远程医疗研究的启示 https://news.medxy.ai/ja/axial-spondyloarthritis-diagnosis/Medxy AIja2026-10-18T07:10:45-07:00遠隔医療による専門家集約レビューで軸性脊椎関節炎の診断精度が向上：多施設研究からの知見 https://news.medxy.ai/vi/axial-spondylitis-diagnosis/Medxy AIvi2026-10-18T07:10:24-07:00Chuyên gia tập trung giúp tăng độ chính xác chẩn đoán viêm cột sống dính khớp trục: Góc nhìn từ nghiên cứu y tế từ xa đa trung tâm https://news.medxy.ai/centralized-expert-review-enhances-diagnostic-accuracy-in-axial-spondyloarthritis-insights-from-a-multicenter-telemedicine-study/Medxy AIen2026-10-18T07:10:06-07:00Centralized Expert Review Enhances Diagnostic Accuracy in Axial Spondyloarthritis: Insights from a Multicenter Telemedicine Study https://news.medxy.ai/immunosuppression-and-long-term-survival-after-single-living-donor-lobar-lung-transplantation-from-the-same-donor-as-prior-hematopoietic-stem-cell-transplantation-an-all-japan-case-series/Medxy AIen2026-10-18T07:09:25-07:00Immunosuppression and Long-term Survival After Single Living-donor Lobar Lung Transplantation from the Same Donor as Prior Hematopoietic Stem Cell Transplantation: An All-Japan Case Series https://news.medxy.ai/zh/labd97-igg-elisa/Medxy AIzh2026-10-18T07:08:39-07:00LABD97 IgG ELISA：提升大疱性类天疱疮诊断敏感性的潜力 https://news.medxy.ai/ja/labd97-igg-elisa-2/Medxy AIja2026-10-18T07:08:20-07:00類天疱瘡の診断感度を高める：LABD97 IgG ELISA の新たな可能性 https://news.medxy.ai/vi/pemphigoid-diagnosis/Medxy AIvi2026-10-18T07:08:01-07:00LABD97 IgG ELISA: Hướng mới giúp nâng cao độ nhạy chẩn đoán pemphigoid bóng nước https://news.medxy.ai/enhancing-diagnostic-sensitivity-for-bullous-pemphigoid-the-emerging-role-of-labd97-igg-elisa/Medxy AIen2026-10-18T07:07:43-07:00Enhancing Diagnostic Sensitivity for Bullous Pemphigoid: The Emerging Role of LABD97 IgG ELISA https://news.medxy.ai/zh/tissue-expander-reconstruction/Medxy AIzh2026-10-18T07:07:06-07:00乳房切除术后胸前组织扩张器重建：新辅助与辅助化疗对结局的影响 https://news.medxy.ai/ja/prechemo-postchemo-te-reconstruction/Medxy AIja2026-10-18T07:06:48-07:00乳房切除後の前胸壁TE再建における術前化学療法と術後補助化学療法の影響 https://news.medxy.ai/vi/chemo-support-breast-reconstruction/Medxy AIvi2026-10-18T07:06:25-07:00Ảnh hưởng của hóa trị tân bổ trợ so với hóa trị bổ trợ đối với kết quả tái tạo vú bằng TE đặt trước cơ sau cắt tuyến vú https://news.medxy.ai/impact-of-neoadjuvant-versus-adjuvant-chemotherapy-on-outcomes-in-prepectoral-tissue-expander-breast-reconstruction-after-mastectomy/Medxy AIen2026-10-18T07:06:03-07:00Impact of Neoadjuvant versus Adjuvant Chemotherapy on Outcomes in Prepectoral Tissue Expander Breast Reconstruction After Mastectomy https://news.medxy.ai/zh/suicide-prevention-among-us-veterans/Medxy AIzh2026-10-18T07:05:23-07:00验证“关怀信件”（Caring Letters）在退伍军人危机热线用户中的自杀预防效果 https://news.medxy.ai/ja/veteran-suicide-prevention/Medxy AIja2026-10-18T07:05:07-07:00退役軍人危機回線利用者における Caring Letters の自殺予防効果を検証する https://news.medxy.ai/vi/suicide-prevention-veterans/Medxy AIvi2026-10-18T07:04:47-07:00Thư quan tâm trong phòng ngừa tự sát ở cựu chiến binh Hoa Kỳ liên hệ với Veterans Crisis Line: kết quả phân tích thứ cấp https://news.medxy.ai/evaluating-caring-letters-for-suicide-prevention-among-us-veterans-contacting-the-veterans-crisis-line/Medxy AIen2026-10-18T07:04:29-07:00Evaluating Caring Letters for Suicide Prevention Among US Veterans Contacting the Veterans Crisis Line https://news.medxy.ai/zh/child-cpr-ventilation/Medxy AIzh2026-10-18T07:03:46-07:00重新审视儿童CPR中的通气频率：年龄分层结局带来的新启示 https://news.medxy.ai/ja/pediatric-cpr-ventilation/Medxy AIja2026-10-18T07:03:27-07:00小児CPRの換気回数を見直す：年齢別転帰から見えてきた新たな知見 https://news.medxy.ai/vi/pediatric-cpr-ventilation-2/Medxy AIvi2026-10-18T07:03:07-07:00Xem xét lại tốc độ thông khí trong CPR nhi khoa: Những phát hiện mới về kết cục khác nhau theo độ tuổi https://news.medxy.ai/reevaluating-ventilation-rates-during-pediatric-cpr-new-insights-into-age-stratified-outcomes/Medxy AIen2026-10-18T07:02:46-07:00Reevaluating Ventilation Rates During Pediatric CPR: New Insights into Age-Stratified Outcomes https://news.medxy.ai/zh/ppm1d-overexpression-tumors/Medxy AIzh2026-10-18T07:02:05-07:00靶向骨髓增殖性肿瘤中的PPM1D过表达：分子机制与治疗进展 https://news.medxy.ai/ja/ppm1d-targeted-therapy/Medxy AIja2026-10-18T07:01:45-07:00骨髄増殖性腫瘍におけるPPM1D過剰発現を標的化する：分子機序の知見と治療の進展 https://news.medxy.ai/vi/ppm1d-overexpression-myeloproliferative/Medxy AIvi2026-10-18T07:01:20-07:00Nhắm đích tình trạng biểu hiện quá mức PPM1D trong u tăng sinh tủy: Hiểu biết phân tử và tiến bộ điều trị https://news.medxy.ai/targeting-ppm1d-overexpression-in-myeloproliferative-neoplasms-molecular-insights-and-therapeutic-advances/Medxy AIen2026-10-18T07:00:57-07:00Targeting PPM1D Overexpression in Myeloproliferative Neoplasms: Molecular Insights and Therapeutic Advances https://news.medxy.ai/ja/ipf-steroid-therapy/Medxy AIja2026-10-18T06:56:11-07:00急性増悪の特発性肺線維症に対するパルス投与と非パルス投与のコルチコステロイド療法：SAFER試験からみたエビデンス統合と臨床的示唆 https://news.medxy.ai/vi/pulse-steroid-ipf/Medxy AIvi2026-10-18T06:55:46-07:00Corticosteroid liều xung hay không liều xung trong đợt cấp xơ phổi vô căn: Tổng hợp bằng chứng và hàm ý lâm sàng từ thử nghiệm SAFER https://news.medxy.ai/pulse-versus-nonpulse-corticosteroid-therapy-in-acute-exacerbation-of-idiopathic-pulmonary-fibrosis-evidence-synthesis-and-clinical-implications-from-the-safer-trial/Medxy AIen2026-10-18T06:55:23-07:00Pulse versus Nonpulse Corticosteroid Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Evidence Synthesis and Clinical Implications from the SAFER Trial https://news.medxy.ai/zh/choroidal-melanoma-radiotherapy/Medxy AIzh2026-10-18T06:54:34-07:00脉络膜黑色素瘤103Pd贴敷近距离放疗的长期结局：第二、第三个十年的视力保留与眼部健康 https://news.medxy.ai/ja/choroidal-melanoma-treatment/Medxy AIja2026-10-18T06:54:14-07:00脈絡膜悪性黒色腫に対する103Pdプラーク小線源治療の長期成績：第2・第3十年における視機能温存と眼内健康への示唆 https://news.medxy.ai/vi/palladium-radiation/Medxy AIvi2026-10-18T06:53:52-07:00Xạ trị áp sát 103Pd trong u hắc tố màng mạch: kết cục dài hạn về bảo tồn thị lực và sức khỏe nhãn cầu ở thập kỷ thứ hai và thứ ba https://news.medxy.ai/long-term-outcomes-of-103pd-plaque-brachytherapy-for-choroidal-melanoma-insights-into-visual-preservation-and-ocular-health-in-the-second-and-third-decades/Medxy AIen2026-10-18T06:53:32-07:00Long-Term Outcomes of 103Pd Plaque Brachytherapy for Choroidal Melanoma: Insights into Visual Preservation and Ocular Health in the Second and Third Decades https://news.medxy.ai/ja/wildfire-air-pollution-cancer-risk/Medxy AIja2026-10-18T06:52:48-07:00山火事由来大気汚染と頭頸部がん発症リスク https://news.medxy.ai/vi/air-pollution-cancer-risk/Medxy AIvi2026-10-18T06:52:27-07:00Ô nhiễm không khí do cháy rừng và nguy cơ ung thư đầu – cổ https://news.medxy.ai/wildfire-air-pollution-exposure-and-head-and-neck-cancer-incidence/Medxy AIen2026-10-18T06:52:08-07:00Wildfire Air Pollution Exposure and Head and Neck Cancer Incidence https://news.medxy.ai/zh/botox-oddi-sphincter-failure/Medxy AIzh2026-10-18T06:51:22-07:00PREBOTPilot试验：向Oddi括约肌注射肉毒毒素未能预防远端胰腺切除术后胰瘘 https://news.medxy.ai/ja/prebotpilot-test-failure/Medxy AIja2026-10-18T06:51:02-07:00PREBOTPilot試験：オッディ括約筋へのボツリヌス毒素注入は遠位膵切除術後の膵瘻予防に失敗 https://news.medxy.ai/prebotpilot-trial-botulinum-toxin-injection-into-the-sphincter-of-oddi-fails-to-prevent-pancreatic-fistula-after-distal-pancreatectomy/Medxy AIen2026-10-18T06:50:22-07:00PREBOTPilot Trial: Botulinum Toxin Injection Into the Sphincter of Oddi Fails to Prevent Pancreatic Fistula After Distal Pancreatectomy https://news.medxy.ai/zh/85554-2-85554/Medxy AIzh2026-10-18T06:49:38-07:00腹腔镜下射频消融术后的治疗失败率是否高于肌瘤剔除术：一项总结最新证据的全面综述 https://news.medxy.ai/ja/laparoscopic-ablation-failure/Medxy AIja2026-10-18T06:49:10-07:00腹腔鏡下高周波アブレーション後の治療失敗は筋腫摘出術より多いのか：最新エビデンスを総括する包括的レビュー https://news.medxy.ai/vi/85552-2-85552/Medxy AIvi2026-10-18T06:48:44-07:00Tỷ lệ thất bại điều trị sau cắt bỏ bằng tần số vô tuyến qua nội soi có cao hơn so với phẫu thuật bóc tách u xơ không? https://news.medxy.ai/treatment-failure-after-laparoscopic-radiofrequency-ablation-compared-with-myomectomy-a-comprehensive-review-of-current-evidence/Medxy AIen2026-10-18T06:48:20-07:00Treatment Failure After Laparoscopic Radiofrequency Ablation Compared With Myomectomy: A Comprehensive Review of Current Evidence https://news.medxy.ai/zh/htpg-colitis-fibrosis/Medxy AIzh2026-10-18T06:47:26-07:00揭示高表达 HtpG 的大肠杆菌在慢性胰腺炎纤维化中的作用：微生物群靶向治疗新希望 https://news.medxy.ai/ja/chronic-pancreatitis-fibrosis/Medxy AIja2026-10-18T06:46:58-07:00慢性膵炎の線維化を駆動するHtpG高発現Escherichia coliの実像：微生物叢標的治療への新たな希望 https://news.medxy.ai/vi/ecoli-htpg-role/Medxy AIvi2026-10-18T06:46:37-07:00Lộ diện vai trò của Escherichia coli biểu hiện HtpG mức cao trong xơ hóa viêm tụy mạn: hy vọng điều trị nhắm vào hệ vi sinh vật https://news.medxy.ai/unveiling-the-role-of-htpg-high-expressing-escherichia-coli-in-chronic-pancreatitis-fibrosis-microbiota-targeted-therapeutic-hope/Medxy AIen2026-10-18T06:46:18-07:00Unveiling the Role of HtpG-High-Expressing Escherichia coli in Chronic Pancreatitis Fibrosis: Microbiota-Targeted Therapeutic Hope https://news.medxy.ai/zh/delpacibart-zotadirsen-in-duchenne-muscular-dystrophy/Medxy AIzh2026-10-18T06:45:32-07:00Delpacibart Zotadirsen 在杜氏肌营养不良症（外显子 44 跳跃治疗适用病例）中的安全性和有效性：来自 EXPLORE44 第 1/2 期试验的发现 https://news.medxy.ai/ja/duschenne-exon44-skip/Medxy AIja2026-10-18T06:45:11-07:00デュシェンヌ型筋ジストロフィーのエクソン44スキッピング適応例におけるDelpacibart Zotadirsenの安全性と有効性：EXPLORE44第1/2相試験からの知見 https://news.medxy.ai/vi/delpacibart-zotadirsen-duchenne-muscular-dystrophy/Medxy AIvi2026-10-18T06:44:46-07:00Tính an toàn và hiệu quả của Delpacibart Zotadirsen ở các trường hợp loạn dưỡng cơ Duchenne phù hợp với liệu pháp bỏ qua exon 44: Những phát hiện từ thử nghiệm giai đoạn 1/2 EXPLORE44 https://news.medxy.ai/safety-and-efficacy-of-delpacibart-zotadirsen-in-duchenne-muscular-dystrophy-amenable-to-exon-44-skipping-insights-from-the-explore44-phase-1-2-trial/Medxy AIen2026-10-18T06:44:13-07:00Safety and Efficacy of Delpacibart Zotadirsen in Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping: Insights from the EXPLORE44 Phase 1/2 Trial